Patient and Public Involvement (PPI) Strategy

At the Oxford Biomedical Research Centre (BRC), we strive to involve members of the public, who may also be patients, and their carers, in our research at all stages. It is only in this way that we can be sure that what we do matters and is acceptable to them.

During 2013/14 we set up our PAIR (Patients Active in Research) group, a mix of patients and professionals, to guide us. We have worked closely with this group as well as a large range of other partners in the region and further afield, to agree a new strategy for patient and public involvement (PPI) to take the BRC and our related Biomedical Research Unit (BRU)  to the end of their current term in 2017. See the BRC-U PPI Strategy 2014-2017

In devising this new strategy our aim has been to focus on heeding best practice in PPI where it is known while developing activities to help our research themes deliver their aims. Furthermore, recognising the huge and fast-growing world of PPI, we have focused on areas not covered by others while building partnerships where beneficial.

The new strategy details plans for:

  • Strategic Partnerships – including – crucially – weaving PPI through our work with the drug and biotech industries
  • Developing PPI across the research cycle
  • The meeting point of involvement, engagement and participation – including a new PPI website
  • Review, monitoring and governance of PPI
  • Sharing good practice, knowledge, skills, resources
  • Growing the evidence base for what works in PPI

By 2017 we thus hope to have embedded a PPI programme that helps deliver the OxBRC/U aims while complementing activity in other organisations locally and further afield.

Engagement activities set out in the strategy will help ensure that patients seen within our hospitals know about the research we do – from trials of new treatments to studies designed to help find out the causes of and ways to prevent disease – and how they can take part.

But crucially, we also hope this new strategy will ensure they also participate in our work across the research cycle, from setting priorities for new research to helping us monitor studies, tell other patients about them and communicate new research findings to other patients and the public.